These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 36746165)
1. Outcome predictors and patient progress following delivery in pregnant and postpartum patients with severe COVID-19 pneumonitis in intensive care units in Israel (OB-COVICU): a nationwide cohort study. Fatnic E; Blanco NL; Cobiletchi R; Goldberger E; Tevet A; Galante O; Sviri S; Bdolah-Abram T; Batzofin BM; Pizov R; Einav S; Sprung CL; van Heerden PV; Ginosar Y; Lancet Respir Med; 2023 Jun; 11(6):520-529. PubMed ID: 36746165 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
3. Critical care, maternal and neonatal outcomes of pregnant women with COVID-19 admitted to eight intensive care units during the wildtype, alpha and delta waves of the pandemic across the North West of England-a retrospective review. Bhatia K; Columb M; Narayan B; Wilson A; Acta Obstet Gynecol Scand; 2023 Dec; 102(12):1719-1729. PubMed ID: 37727968 [TBL] [Abstract][Full Text] [Related]
4. Treatment of pregnant and early postpartum women with severe and critical COVID-19: experience at a tertiary center. Barbosa RN; Braga MA; Costa BB; Peret FJA Eur J Med Res; 2022 Dec; 27(1):269. PubMed ID: 36461042 [TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes of pregnant women with severe COVID-19 requiring extracorporeal membrane oxygenation (ECMO): a case series and literature review. Clemenza S; Zullino S; Vacca C; Simeone S; Serena C; Rambaldi MP; Ottanelli S; Vannuccini S; Bonizzoli M; Peris A; Micaglio M; Petraglia F; Mecacci F Arch Gynecol Obstet; 2022 May; 305(5):1135-1142. PubMed ID: 35262778 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A; Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674 [TBL] [Abstract][Full Text] [Related]
7. Performance of the Obstetric Early Warning Score in critically ill patients for the prediction of maternal death. Paternina-Caicedo A; Miranda J; Bourjeily G; Levinson A; Dueñas C; Bello-Muñoz C; Rojas-Suarez JA Am J Obstet Gynecol; 2017 Jan; 216(1):58.e1-58.e8. PubMed ID: 27751799 [TBL] [Abstract][Full Text] [Related]
8. Maternal and Neonatal Outcomes of Critically Ill Pregnant and Puerperal Patients Diagnosed with COVID-19 Disease: Retrospective Comparative Study. Eman A; Balaban O; Kocayiğit H; Süner KÖ; Cırdı Y; Erdem AF J Korean Med Sci; 2021 Nov; 36(44):e309. PubMed ID: 34783218 [TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of critically ill pregnant women with different admission methods to intensive care unit: data analysis from 2006 to 2019 in the university hospital]. Xi J; Ren H; Zhang H; Zhao Z; Wang T; Wang Z; Li W; Bo S; Yao G; Zhao Y; Wang Y; Ge Q Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1249-1254. PubMed ID: 34955137 [TBL] [Abstract][Full Text] [Related]
10. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292 [TBL] [Abstract][Full Text] [Related]
11. Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study. Charles CM; Osman NB; Arijama D; Matingane B; Sitoé T; Kenga D; Lorenzoni C; Luís E; Pacagnella RC; Sacarlal J; Reprod Health; 2022 Jul; 19(1):164. PubMed ID: 35854384 [TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Pregnant/Puerperal Women with COVID-19 Admitted to ICU in Turkey: A Multicenter, Retrospective Study from a Middle-Income Country. Baykara N; J Intensive Care Med; 2024 Jun; 39(6):577-594. PubMed ID: 38320979 [TBL] [Abstract][Full Text] [Related]
13. [Pregnant women with COVID-19 ARDS on the intensive care unit]. Kalbhenn J; Marx O; Müller-Peltzer K; Kunze M; Bürkle H; Bansbach J Anaesthesiologie; 2024 Jun; 73(6):385-397. PubMed ID: 38671334 [TBL] [Abstract][Full Text] [Related]
14. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
15. Outcomes Following Extracorporeal Membrane Oxygenation for Severe COVID-19 in Pregnancy or Post Partum. Byrne JJ; Shamshirsaz AA; Cahill AG; Turrentine MA; Seasely AR; Eid J; Rouse CE; Richley M; Raghuraman N; Naqvi M; El-Sayed YY; Badell ML; Cheng C; Liu J; Adhikari EH; Patel SS; O'Neil ER; Ramsey PS JAMA Netw Open; 2023 May; 6(5):e2314678. PubMed ID: 37213099 [TBL] [Abstract][Full Text] [Related]
16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
19. Variability in intensive care unit admission among pregnant and postpartum women in Canada: a nationwide population-based observational study. Aoyama K; Pinto R; Ray JG; Hill AD; Scales DC; Lapinsky SE; Hladunewich M; Seaward GR; Fowler RA Crit Care; 2019 Nov; 23(1):381. PubMed ID: 31775866 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]